Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael P Bancks

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Diabetes Care|May 23, 2023
Absolute Benefits From Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 InhibitorsMichael P Bancks
Diabetes Care|January 11, 2023
Assessment for Gender Differences in Trend in Age at Diagnosis of Diabetes Among U.S. Adults, 1999-2020Anna R McPherson, Michael P Bancks
Diabetes Research and Clinical Practice|November 10, 2019
Epidemiology of diabetes phenotypes and prevalent cardiovascular risk factors and diabetes complications in the National Health and Nutrition Examination Survey 2003-2014Michael P Bancks, Ramon Casanova, Edward W Gregg, et al.
Scientific Reports|December 28, 2023
Trajectory modeling of cannabis use over 30 years identifies five unique longitudinal patternsAmy R Mahar, Michael P Bancks, Stephen Sidney, et al.
The Journal of Clinical Endocrinology and Metabolism|April 23, 2025
Development and validation of a diabetes risk prediction model with individualized preventive intervention effectsByron Jaeger, Ramon Casanova, Yitbarek Demesie, et al.
Diabetes Care|February 2, 2026
Estimated Optimal Individualized Diabetes Risk Prediction From Preventive Interventions in the U.S. General PopulationJeanette M Stafford, Byron Jaeger, Ramon Casanova, et al.
Diabetes, Obesity & Metabolism|July 10, 2024
Efficacy of Aspirin for primary prevention among adults with high-risk type 2 diabetes in the ACCORD trialRichard Kazibwe, Matthew Singleton, Michael P Bancks, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 19, 2017
Brain function and structure and risk for incident diabetes: The Atherosclerosis Risk in Communities StudyMichael P Bancks, Alvaro Alonso, Rebecca F Gottesman, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|March 21, 2022
Developing a Data Quality Standard Primer for Cardiovascular Risk Assessment from Electronic Health Record Data Using the DataGauge ProcessFranck Diaz-Garelli, Andrew Long, Michael P Bancks, et al.
The Journal of Clinical Endocrinology and Metabolism|June 11, 2025
Prediabetes subgroups, type 2 diabetes risk, and differential effects of preventive interventionsJeanette M Stafford, Ramon Casanova, Byron C Jaeger, et al.
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Diabetes Care|May 23, 2023
Absolute Benefits From Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 InhibitorsMichael P Bancks
Diabetes Care|January 11, 2023
Assessment for Gender Differences in Trend in Age at Diagnosis of Diabetes Among U.S. Adults, 1999-2020Anna R McPherson, Michael P Bancks
Diabetes Research and Clinical Practice|November 10, 2019
Epidemiology of diabetes phenotypes and prevalent cardiovascular risk factors and diabetes complications in the National Health and Nutrition Examination Survey 2003-2014Michael P Bancks, Ramon Casanova, Edward W Gregg, et al.
Scientific Reports|December 28, 2023
Trajectory modeling of cannabis use over 30 years identifies five unique longitudinal patternsAmy R Mahar, Michael P Bancks, Stephen Sidney, et al.
The Journal of Clinical Endocrinology and Metabolism|April 23, 2025
Development and validation of a diabetes risk prediction model with individualized preventive intervention effectsByron Jaeger, Ramon Casanova, Yitbarek Demesie, et al.
Diabetes Care|February 2, 2026
Estimated Optimal Individualized Diabetes Risk Prediction From Preventive Interventions in the U.S. General PopulationJeanette M Stafford, Byron Jaeger, Ramon Casanova, et al.
Diabetes, Obesity & Metabolism|July 10, 2024
Efficacy of Aspirin for primary prevention among adults with high-risk type 2 diabetes in the ACCORD trialRichard Kazibwe, Matthew Singleton, Michael P Bancks, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 19, 2017
Brain function and structure and risk for incident diabetes: The Atherosclerosis Risk in Communities StudyMichael P Bancks, Alvaro Alonso, Rebecca F Gottesman, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|March 21, 2022
Developing a Data Quality Standard Primer for Cardiovascular Risk Assessment from Electronic Health Record Data Using the DataGauge ProcessFranck Diaz-Garelli, Andrew Long, Michael P Bancks, et al.
The Journal of Clinical Endocrinology and Metabolism|June 11, 2025
Prediabetes subgroups, type 2 diabetes risk, and differential effects of preventive interventionsJeanette M Stafford, Ramon Casanova, Byron C Jaeger, et al.
Pageof 10